1. 179P Early proof of concept of safety and clinical activity of clonal neoantigen-reactive T cells (cNeT). (December 2022) Authors: Forster, M.D.; Cave, J.; Greystoke, A.; Plummer, R.; Spicer, J.; Thistlethwaite, F.; Turajlic, S.; Craig, A.; Newton, K.; Saggese, M.; Quezada, S.; Peggs, K. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗